Call for Abstract

International Conference on Stress Management, will be organized around the theme “”

Stress Management Meet 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Stress Management Meet 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Brain Tumors
  • Track 1-2Craniotomy.
  • Track 1-3Ventricular Shunt
  • Track 1-4Spine Surgery
  • Track 1-5Traumatic Injuries
  • Track 2-1Brain damage
  • Track 2-2Frontal lobe damage
  • Track 2-3Parietal lobe damage
  • Track 2-4Temporal lobe damage
  • Track 2-5Occipital lobe damage
  • Track 3-1Ankylosing spondylitis
  • Track 3-2Scoliosis
  • Track 4-1Ischemic Stroke
  • Track 4-2Hemorrhagic Stroke
  • Track 4-3TIA (Transient Ischemic Attack)
  • Track 4-4Brain Stem Stroke
  • Track 4-5Cryptogenic Stroke
  • Track 5-1Ependymomas
  • Track 5-2Astrocytomas
  • Track 5-3Oligodendrogliomas
  • Track 6-1Genetic diseases of the nervous system.
  • Track 6-2Neurological developmental problems during childhood
  • Track 6-3Febrile seizures
  • Track 6-4Movement disorders such as cerebral palsy
  • Track 6-5Childhood epilepsy.
  • Track 7-1Aneurysm.
  • Track 7-2Arterial dissection.
  • Track 7-3Arteriorvenous fistulae.
  • Track 7-4Cavernous malformation.
  • Track 7-5Hemangioma.
  • Track 7-6Moyamoya syndrome.
  • Track 8-1Primary tumors of the central nervous system
  • Track 8-2Metastatic tumors of the central nervous system
  • Track 8-3Intracranial metastasis
  • Track 8-4Skull metastasis
  • Track 9-1Neuropsychologist
  • Track 9-2Therapeutic Recreation Specialists
  • Track 9-3Traumatic brain injury
  • Track 10-1Diffuse Optical Imaging
  • Track 10-2Magnetic Resonance Imaging
  • Track 10-3Cranial Ultrasound
  • Track 11-1Voxel Based Morphometry (VBM)
  • Track 11-2Magneto Encephalography (MEG)
  • Track 11-3Diffusion Tensor Imaging (DTI)
  • Track 11-4Optical imaging
  • Track 11-5Diffusion Tensor Imaging (DTI)
  • Track 11-6 Electroencephalography (EEG)
  • Track 11-7Positron Emission Tomography (PET).
  • Track 12-1Anosognosia
  • Track 12-2Aphasias
  • Track 12-3Dementia
  • Track 13-1Causal pluralism
  • Track 13-2Mind/brain monism
  • Track 13-3Clinical Neuropsychology
  • Track 13-4Forensic Neuropsychology
  • Track 13-5Cognitive Neuropsychology
  • Track 14-1Neurotransmitter
  • Track 14-2Neuromodulator
  • Track 14-3Neurotoxin
  • Track 14-4Chemotherapy
  • Track 14-5Drug therapies
  • Track 15-1Neural stem cell fate
  • Track 15-2Neurodevelopmental disorders
  • Track 15-3Neurodegenerative disorders
  • Track 15-4Psychosomatic illness
  • Track 16-1Neurochemical interactions
  • Track 16-2Molecular neuropharmacology
  • Track 16-3Behavioral neuropharmacology
  • Track 17-1Focal hyperhidrosis
  • Track 17-2Cervical dystonia
  • Track 17-3Peripheral neuropathies